Fidelity International’s Counterpath Corp CPAH Stock Holding History

Fidelity International’s Portfolio CPAH Stock Details CPAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-257,950	Closed	-$431K	–	1018
2019 Q1	$431K	Hold	257,950	–	–	﹤0.01%	650
2018 Q4	$310K	Sell	257,950 -26,500	-9%	-$50.8K	﹤0.01%	663
2018 Q3	$569K	Hold	284,450	–	–	﹤0.01%	651
2018 Q2	$680K	Buy	+284,450	New	+$727K	﹤0.01%	647

Other funds holding CPAH

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity International's CPAH Position: Q2 2019 in Review

Fidelity International sold out of Counterpath Corp (CPAH) in Q2 2019, closing a stake of 257,950 shares — an estimated $431K sold.

Fidelity International first reported a position in CPAH in Q2 2018 and held it in 4 quarters. The position peaked at $680K in Q2 2018. 10 funds tracked by Wall St. Rank hold CPAH as of Q2 2019.

Fidelity International reported no remaining Counterpath Corp position as of Q2 2019 after selling out during the quarter.
Fidelity International sold 257,950 Counterpath Corp shares in Q2 2019, an estimated $431K.
Fidelity International first reported a position in Counterpath Corp in Q2 2018 and held it in 4 quarters.
Fidelity International's Counterpath Corp position peaked at $680K in Q2 2018.
10 funds tracked by Wall St. Rank held Counterpath Corp as of Q2 2019.

Based on Fidelity International's 13F filing for Q2 2019, filed 13 Aug 2019.